SCM
PTGX icon

Silverarc Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Silverarc Capital Management’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-146,657
Closed -$6.6M – 78
2024
Q3 		$6.6M Buy
+146,657
New +$5.93M 1.49% 21
2023
Q3 		– Sell
-25,000
Closed -$691K – 98
2023
Q2 		$691K Sell
25,000
-80,486
-76% -$2.01M 0.23% 65
2023
Q1 		$2.43M Buy
+105,486
New +$1.77M 1.09% 39
2021
Q1 		– Sell
-20,910
Closed -$422K – 100
2020
Q4 		$422K Buy
+20,910
New +$450K 0.26% 75

Other funds holding PTGX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return